AbbVie (ABBV) Retained Earnings (2012 - 2026)

AbbVie has disclosed Retained Earnings across 15 years of filings, most recently posting -$17.9 billion for Q1 2026.

• In Q1 2026, Retained Earnings fell 925.95% year-over-year to -$17.9 billion; the TTM figure through Mar 2026 stood at -$17.9 billion (down 925.95% YoY), while the FY2025 annual figure was -$1.1 billion, up 85.52% from the prior year.
• Retained Earnings eased to -$17.9 billion in Q1 2026, from -$1.1 billion in the prior quarter.
• Over the last five years, Retained Earnings for ABBV reached as high as $5.1 billion in Q1 2022 and fell as low as -$17.9 billion in Q1 2026.
• The 5-year median for Retained Earnings is -$1.7 billion (2025), against an average of -$2.7 billion.
• Annual changes were most pronounced in 2022 — Retained Earnings surged 213.31% — and 2026, when it plunged 925.95%.
• A 5-year view of Retained Earnings shows it stood at $4.8 billion in 2022, then plunged by 120.9% to -$1.0 billion in 2023, then slumped by 690.0% to -$7.9 billion in 2024, then soared by 85.52% to -$1.1 billion in 2025, then plunged by 1462.24% to -$17.9 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$17.9 billion, -$1.1 billion, and -$14.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.